JPS63284110A - Extract of seed of cuscuta japonica choisy - Google Patents
Extract of seed of cuscuta japonica choisyInfo
- Publication number
- JPS63284110A JPS63284110A JP62120367A JP12036787A JPS63284110A JP S63284110 A JPS63284110 A JP S63284110A JP 62120367 A JP62120367 A JP 62120367A JP 12036787 A JP12036787 A JP 12036787A JP S63284110 A JPS63284110 A JP S63284110A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- solvent
- seed
- cuscuta japonica
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 32
- 241001609679 Cuscuta japonica Species 0.000 title abstract 4
- 210000002374 sebum Anatomy 0.000 claims abstract description 19
- 230000028327 secretion Effects 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 230000001737 promoting effect Effects 0.000 claims abstract description 9
- 235000015701 Artemisia arbuscula Nutrition 0.000 claims description 4
- 235000002657 Artemisia tridentata Nutrition 0.000 claims description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 4
- 240000006891 Artemisia vulgaris Species 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002537 cosmetic Substances 0.000 abstract description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 239000003021 water soluble solvent Substances 0.000 abstract description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 abstract 1
- 210000001732 sebaceous gland Anatomy 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 239000000469 ethanolic extract Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000002035 hexane extract Substances 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- -1 pantethine fatty acid esters Chemical class 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 208000019300 CLIPPERS Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 238000000944 Soxhlet extraction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- YXQXLHSRJUFMFD-UHFFFAOYSA-N 3-[(3,4-dihydroxyphenyl)methyl]-2h-chromene-7,8-diol Chemical group C1=C(O)C(O)=CC=C1CC1=CC2=CC=C(O)C(O)=C2OC1 YXQXLHSRJUFMFD-UHFFFAOYSA-N 0.000 description 1
- 101100410786 Arabidopsis thaliana PXG5 gene Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000244177 Strongyloides stercoralis Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野]
本発明は皮脂分泌促進作用を有することを特徴とする菟
糸子の溶媒抽出液および/またはその溶媒を留去して得
られる抽出物に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a solvent extract of sagebrush and/or an extract obtained by distilling off the solvent, which is characterized by having a sebum secretion promoting effect.
(従来の技術)
皮膚および毛髪の若々しさ、美しさは皮脂分泌によると
ころが大であり、この皮脂分泌が高齢化と共に減少して
いくことが、肌荒れ、皮膚の乾燥化への原因の一つと考
えられている。皮脂分泌促進作用、すなわち皮脂腺細胞
賦活作用を有する物質は、皮脂の分泌機能が低下したヒ
トの肌に対し、皮脂腺の機能を賦活化させ、再び若々し
い皮膚をとりもどすことができる、いわゆる中、高齢者
向きの化粧料等の基剤として有効であると考える。(Conventional technology) The youthfulness and beauty of skin and hair is largely due to sebum secretion, and the decline in sebum secretion as we age is one of the causes of rough skin and dry skin. It is considered. Substances that have a sebum secretion promoting effect, that is, a sebaceous gland cell activating effect, can activate the sebaceous gland function of human skin whose sebum secretion function has decreased and restore youthful skin. It is considered to be effective as a base for cosmetics etc. for the elderly.
又、皮脂腺の萎縮や機能低下が原因と考えられる疾患に
対しても有用な外用剤として期待できる。It is also expected to be a useful topical agent for diseases thought to be caused by sebaceous gland atrophy or functional decline.
しかしながら、皮脂分泌促進剤として知られる物質は、
r−オリザノール〔小林美恵ら、西日本皮膚科(197
2)566参照〕、パンテチン脂肪酸エステル類(特告
昭60−19726号公報)など歩測があげられるのみ
であり、又、満足すべき効果を有するものがないのが現
状である。そこで、特に皮脂分泌を促進する物質が望ま
れている。However, substances known as sebum secretion enhancers,
r-oryzanol [Mie Kobayashi et al., West Japan Dermatology (197
2) No. 566] and pantethine fatty acid esters (Japanese Patent Publication No. 19726/1982), there are only pedometers available, and at present there is no product that has a satisfactory effect. Therefore, a substance that particularly promotes sebum secretion is desired.
(発明が解決しようとする問題点]
本発明者らは、さらに優れた皮脂分泌促進剤を発明すべ
く鋭意探索研究した結果、生薬として知られている菟糸
子の溶媒抽出液および/またはその溶媒を留去して得ら
れる抽出物に皮脂の分泌を著しく促進する作用があるこ
とを見出し、本発明を完成した。(Problems to be Solved by the Invention) As a result of intensive exploration and research in order to invent an even better sebum secretion promoter, the present inventors have found that a solvent extract of sagebrush, which is known as a crude drug, and/or a solvent thereof. The present invention was completed based on the discovery that the extract obtained by distilling off the sebum has the effect of significantly promoting sebum secretion.
(間厘点を解決するための手段]
本発明で用いる菟糸子は、ヒルガオ科、ネナシカズラ属
のネナシカズラ(0uscuta j aponica
OhO1li7 ) Xハマネナシカズラ(0,ohi
nenai@Lam)、vメダオシ(0,aua tr
alia R−BT−) 、アマダオシ(a、 sp
ilinum Vein ) などの種子をいい、古
くから強精、強壮効果を有する生薬として用いられてい
る。(Means for solving the problem) The iris used in the present invention is from the family Convolvulaceae.
OhO1li7)
nenai@Lam), v Medaoshi (0, aua tr
alia R-BT-), Amadaoshi (a, sp
ilinum vein), and has been used as a herbal medicine with tonic and tonic effects since ancient times.
本発明の菟糸子の溶媒抽出液は、克糸子の粉末を、例え
ば、メタノール、エタノール、水等の水溶性溶媒や、n
−ヘキサン、クロロホルム、エチルエーテル、ベンゼン
等の有機溶媒の各単独力、あるいはそれらの混合物で抽
出したものである。The solvent extract of Katsushiko of the present invention is prepared by extracting Katsushiko powder using a water-soluble solvent such as methanol, ethanol, water, etc.
- Extraction with organic solvents such as hexane, chloroform, ethyl ether, benzene, etc., or a mixture thereof.
これらは必要に応じて濃縮および希釈することができる
。また、本発明の抽出物は、上記の各種溶媒抽出液から
、それぞれ、溶媒を常法に従って留去することによって
得ることができる。抽出操作(抽出温度)は、冷温、室
温、高温のいずれの場合でもよい。These can be concentrated and diluted as necessary. Further, the extract of the present invention can be obtained by distilling off the solvent from each of the above-mentioned various solvent extracts according to a conventional method. The extraction operation (extraction temperature) may be performed at cold temperature, room temperature, or high temperature.
本発明の晃糸子の溶媒抽出液および/またはその溶媒を
留去することによって得られる抽出物は、常法に従って
化粧料あるいは、皮膚外用剤などの医薬品に配合するこ
とができ、その配合量は、化粧料あるいは皮膚外用剤な
どの全重量に対して、抽出物として通常0.001〜3
0重量%、好ましくは0.01〜10重量%配合するの
が適量である。The solvent extract of the present invention and/or the extract obtained by distilling off the solvent can be blended into cosmetics or pharmaceuticals such as external skin preparations according to a conventional method, and the amount of blending is , usually 0.001 to 3 as an extract based on the total weight of cosmetics or external skin preparations, etc.
A suitable amount is 0% by weight, preferably 0.01 to 10% by weight.
配合量が0.001重量%以下では充分な効果が得られ
ず、また、30重量%を超える量では効果の増強がない
ので不経済である。If the amount is less than 0.001% by weight, a sufficient effect cannot be obtained, and if the amount exceeds 30% by weight, the effect will not be enhanced, which is uneconomical.
実施例 以下、実施例を示しつつ、本発明を具体的に説明する。Example The present invention will be specifically described below with reference to Examples.
なお、本発明の内容はこれらに限定されるものではない
。実施例に示す部とは重量部を、弧とは重量イを意味す
る。Note that the content of the present invention is not limited to these. The parts shown in the examples mean parts by weight, and the arcs mean parts by weight.
実施例1
晃糸子粉末100gをエタノール400 dに浸し、2
時間加熱還流した後、4紙4.過する。その4、過動を
さらに200露lのエタノールで洗浄後、4、液および
洗液を合わせ、減圧下で濃縮し、菟糸子エタノール抽出
液を得た。Example 1 Soak 100 g of Koitoko powder in 400 d of ethanol,
After heating under reflux for an hour, 4 sheets of paper 4. pass After washing the 4. hyperactivity with 200 liters of ethanol, the 4. solution and the washing solution were combined and concentrated under reduced pressure to obtain an ethanolic extract of iris.
実施例2
蔓糸子粉末100gをエタノール400 mlに浸し、
2時間加熱還流した後、違3紙4.過する。その4、過
動をさらに200 mlのエタノールで洗浄後1違、液
および洗液を合わせ、減圧下で濃縮乾固し、モ糸子エタ
ノール抽出物を得た。Example 2 Soak 100 g of vine powder in 400 ml of ethanol,
After heating under reflux for 2 hours, 4. pass Step 4: After washing the excess fluid with 200 ml of ethanol, the solution and the washing solution were combined and concentrated to dryness under reduced pressure to obtain an ethanolic extract of Moito.
実施例3
菟糸子100gをn−ヘキサン400 ytlを用いて
24時間ソックスレー抽出した後、違0紙燻、過し、1
液を減圧下で濃縮し、菟糸子n−へキサン抽出液を得た
。Example 3 After Soxhlet extraction of 100 g of iris using 400 ytl of n-hexane for 24 hours,
The liquid was concentrated under reduced pressure to obtain an n-hexane extract of iris.
実施例4
菟糸子100gをn−ヘキサン400 mlを用し)で
24時間ソックスレー抽出した後、鴫1紙違過し、傭液
を減圧下で濃縮乾固し、晃糸子n−ヘキサン抽出物を得
た。Example 4 After 24 hours of Soxhlet extraction of 100 g of Koishi with 400 ml of n-hexane, the extract was filtered through a sheet of paper, and the liquid was concentrated to dryness under reduced pressure to obtain the n-hexane extract of Koishitoko. Obtained.
実施例5
0.1%配合クリーム
■ステアリン!! 40部■セチ
ルアルコール 30■ステアリルアル
コール 10■流動パラフイン
6.5■白色ワセリン 1
0.0■ソルビタンモノステアレー) 15■ポ
リオキシエチレン(25)
モノステアレート 3.0■IA子エ
タノール抽出物 01■グリセリン
50[相]水醸化カリウム
0.2■勤噌馴購パラオキシ安息香酸メチル
0.2■精製水 65.
5〔製法〕成分■〜■および成分■〜@をそれぞれ70
〜75℃に加温溶解した後、成分Φ〜■に成分■〜@を
加えて乳化し、30℃まで冷却し製品とする。Example 5 0.1% cream ■Stearin! ! 40 parts ■ Cetyl alcohol 30 ■ Stearyl alcohol 10 ■ Liquid paraffin
6.5 ■White Vaseline 1
0.0 ■ Sorbitan monostearate) 15 ■ Polyoxyethylene (25) monostearate 3.0 ■ IA child ethanol extract 01 ■ Glycerin
50 [Phase] Suijoka Potassium
0.2■Methyl paraoxybenzoate
0.2 ■ Purified water 65.
5 [Manufacturing method] Ingredients ■~■ and ingredients ■~@70 each
After heating and dissolving at ~75°C, components Φ~■ are emulsified by adding components ■~@, and cooled to 30°C to form a product.
実施例6
1%配合軟膏剤
■精製ラノリン 5.0部■サラ
シミッロウ 5.00菟糸子n−
ヘキサン抽出物 t00白色ワセリン
89.0〔製法〕各成分を加熱溶解して
混合した後、冷却し製品とする。Example 6 1% combination ointment ■ Purified lanolin 5.0 parts ■ Sarashimiro 5.00 Uitoko n-
Hexane extract t00 white petrolatum
89.0 [Manufacturing method] After heating and melting each component and mixing, the product is cooled.
実施例7
α01弧配合化粧水
■菟糸子水抽出物 αo1部■グリ
セリン 4.0■t3ブチレン
グリコール 五〇〇エチルアルコール
7.00ポリオキシエチレン(20)
ラウリルエーテル α5■パラオキシ安
息香酸メチル α1■クエン醗
α010クエン酸ナトリウム
α1■香料
CLO5@緑色3号 αo
ooot■精製水を加えて100とする。Example 7 Lotion containing α01-arc ■ Bottle thread water extract 1 part αo ■ Glycerin 4.0 ■ T3 butylene glycol 500 ethyl alcohol
7.00 Polyoxyethylene (20) Lauryl ether α5 ■ Methyl paraoxybenzoate α1 ■ Citric alcohol
α010 Sodium Citrate
α1 ■Fragrance
CLO5@Green No.3 αo
ooot ■ Add purified water to make 100.
〔製法〕成分■〜Φ、成分Φ及び■を混合して溶解する
。別に成分■、01の、■、0及び0を混合して溶解す
る。次で両者を混合し、テフpン製布(300メツシI
L)によりろ過し製品とする@実施例8
2襲配合乳液
■1糸子エチルエーテル抽出物2.0@■スクワラン
5.00オリーブ油
5.0Φホホバ油
5.00セチルアルコール
t5■グリセリンモノステアレート2.0
のポリオキシエチレン(20]
竜チルエーテル 5.00〆リオキシ
エチレン(20)
ソルビタンモノステアレート 2.0■ジプロピレ
ングリコール 五5[株]グリセリン
5.50香料
α1Oパラオキシ安息香酬メチル α3■
精製水を加えて100とするO
〔製法〕成分■〜■を加熱溶解して混合し、70℃に保
ち油相とする。成分■、■、[株]、O及び0を加熱溶
解して混合し75℃に保ち水相とする。油相に水相を加
え、さらに成分■を加えてホモミキサーで均一に乳化後
、かき混ぜながら30℃まで冷却して製品とする。[Manufacturing method] Components ⑦ to Φ, components Φ and ⑦ are mixed and dissolved. Separately, components (1), 01, (2), 0, and 0 are mixed and dissolved. Next, mix the two and use Teflon cloth (300 mesh I).
L) to make a product @Example 8 Two-stage combination emulsion ■1 Thread ethyl ether extract 2.0 @ ■ Squalane
5.00olive oil
5.0Φjojoba oil
5.00 cetyl alcohol
t5 ■ Glycerin monostearate 2.0 Polyoxyethylene (20) Ryuthyl ether 5.00 Lioxyethylene (20) Sorbitan monostearate 2.0 ■ Dipropylene glycol 55 [Co., Ltd.] Glycerin
5.50 fragrance
α1O paraoxybenzoyl methyl α3■
Add purified water to make 100 O. [Production method] Components (1) to (2) are heated and dissolved, mixed, and kept at 70°C to form an oil phase. Ingredients (1), (2), [Co., Ltd.], O and 0 are heated and dissolved, mixed and kept at 75°C to form an aqueous phase. Add the aqueous phase to the oil phase, then add ingredient (1) and homogeneously emulsify with a homomixer, then cool to 30°C while stirring to obtain a product.
(発明の効果)
本発明の覧糸子の溶媒抽出液および/またはその溶媒を
留失して得られる抽出物は著しい皮脂分泌促進効果を示
した。(Effects of the Invention) The solvent extract of the threadworm of the present invention and/or the extract obtained by distilling off the solvent showed a remarkable sebum secretion promoting effect.
以下に、試験例によって本発明の効果を示す。The effects of the present invention will be shown below through test examples.
試験例1
実施例2で得られた菟糸子のエタノール抽出物5gをエ
タノール95g中に溶解させ、本発明の皮脂分泌促進剤
の皮脂腺賦活作用試験の試料とした。実施例2と同様な
方法により、水抽出物、メタノール抽出物も調製し、上
記の様にして試験試料とした。又、実施例4で得られた
n−へキサン抽出物5gをエタノール95g中に溶解し
、本発明の試験試料とした。実施例4と同様な操作によ
りエチルエーテル抽出物、クロロホルム抽出物も調製し
上記の様にして試験試料とした。Test Example 1 5 g of the ethanolic extract of the iris obtained in Example 2 was dissolved in 95 g of ethanol and used as a sample for the sebaceous gland activation effect test of the sebum secretion promoter of the present invention. A water extract and a methanol extract were also prepared in the same manner as in Example 2, and used as test samples as described above. In addition, 5 g of the n-hexane extract obtained in Example 4 was dissolved in 95 g of ethanol and used as a test sample of the present invention. An ethyl ether extract and a chloroform extract were also prepared in the same manner as in Example 4 and used as test samples as described above.
実験動物として工ORマウス(雄、6週齢、平均体重2
6g)を用い、背部から両側腹部全体をバリカンにて刈
毛した。翌日より本発明の試験試料を被験部皮膚に毎日
、朝夕2回、1回当たりα11jを塗布した。動物は一
群8匹とし、実験動物の右側腹部に試料を、左側腹部に
対照としてエタノールを塗布した。塗布開始11日目に
マウスを層殺し、試料およびエタノール塗布部の皮膚を
採取し、10q&中性ホルマリンにて固定した。常法に
従い組織病理標本を作製し、染色はヘマトキシレン・エ
オシンで二重染色を行った。皮脂腺賦活の指標として皮
脂腺を構成する細胞のカウントを行った。皮脂HIa胞
のカウントは、組Ia礪本から任意の15個の皮脂腺を
選択し、それぞれの皮脂腺を構成する細#l数を光学顕
微鏡下でカウントした。15個の平均値を算出し、その
値をその試料の皮脂腺細胞数としてあられした。又、同
じ個体のエタノール塗布部の皮脂腺細胞数を同様に測定
し、エタノール塗布部の細胞数に対する試料塗結果は第
1表に示す通り、いずれの抽出物も顕著に皮脂腺細胞数
を増加させた。又、オリーブ油や皮脂腺賦活作用を有す
る化粧品原料として知られるγ−オリザノールと比較し
ても、いずれの抽出物も統計的に有意な差をもって皮脂
腺細胞数を増加させた。Experimental animals were engineered OR mice (male, 6 weeks old, average weight 2
Using hair clippers (6g), the entire area from the back to both sides of the abdomen was trimmed with clippers. Starting from the next day, the test sample of the present invention was applied to the skin of the test subject twice daily, once in the morning and once in the evening, α11j was applied each time. There were 8 animals in each group, and the sample was applied to the right flank of the experimental animals, and ethanol was applied to the left flank as a control. On the 11th day after the start of application, the mice were sacrificed, and samples and the skin of the ethanol-applied area were collected and fixed with 10q&neutral formalin. Histopathological specimens were prepared according to conventional methods, and double staining was performed with hematoxylene and eosin. Cells constituting sebaceous glands were counted as an indicator of sebaceous gland activation. To count sebaceous HIa cells, 15 arbitrary sebaceous glands were selected from Group Ia cells, and the number of cells constituting each sebaceous gland was counted under an optical microscope. The average value of the 15 samples was calculated, and the value was expressed as the number of sebaceous gland cells of the sample. In addition, the number of sebaceous gland cells in the ethanol-applied area of the same individual was measured in the same way, and the sample coating results for the cell number in the ethanol-applied area are shown in Table 1. All extracts significantly increased the number of sebaceous gland cells. . Furthermore, when compared with olive oil and γ-oryzanol, which is known as a cosmetic raw material with sebaceous gland activating effects, all extracts increased the number of sebaceous gland cells with a statistically significant difference.
第1表
第1表の結果から明らかなように、本発明の菟糸子の各
種溶媒による抽出物は、著しい皮脂腺細胞賦活作用を有
しており、皮脂分泌促進効果が示された。As is clear from the results shown in Table 1, the extracts of the iris of the present invention using various solvents had a significant sebaceous gland cell activating effect, and were shown to have a sebum secretion promoting effect.
なお、本発明において、菟糸子の抽出物を単独でmいて
もよいが、例えば、生薬として知られている先活、遠志
、セネガ、女貞子および桑寄生の抽出物と併用すると、
菟糸子抽出物単独のときよりも良好な皮脂腺細胞賦活作
用が得られた。これらの生薬の抽出物は、菟糸子の抽出
物と1種以上の組合せで用いることができる。In addition, in the present invention, the extract of iris may be used alone, but for example, when used in combination with the extracts of sakatsu, toshi, senega, onna-sadako, and mulberry parasitic, which are known as herbal medicines,
A better sebaceous gland cell activating effect was obtained than when using the iris extract alone. Extracts of these herbal medicines can be used in combination with one or more of the extracts of sagebrush.
試験例2
実施例2で得た(朱子エタノール抽出物の0.1外用し
、その皮脂分泌促進効果を検定した。Test Example 2 0.1 of the vermilion ethanol extract obtained in Example 2 was applied externally to examine its sebum secretion promoting effect.
健常人20名(男性10名、女性10名、平均年齢34
才]を対象に試験を行った。まず10名の左前腕内側部
に0.1%配合クリームを、右前腕内側部に抽出物を含
まない同処方のクリームを1日3回、30日間連続、適
量塗布した。同様に、他の10名については右前腕内側
部に1%配合軟膏剤を、左前腕内側部に抽出物を含まな
い同処方の軟膏剤を1日3回、30日間連続、適量塗布
した。31日目に一カップ法にて皮脂分泌量を測定した
。20 healthy people (10 men, 10 women, average age 34)
The test was conducted on people of all ages. First, 10 people applied an appropriate amount of a cream containing 0.1% to the inside of their left forearm, and an appropriate amount of cream containing no extract to the inside of their right forearm, three times a day for 30 consecutive days. Similarly, the other 10 subjects applied an appropriate amount of a 1% ointment on the inside of their right forearm and an ointment with the same formulation without extract on the inside of their left forearm three times a day for 30 consecutive days. On the 31st day, sebum secretion was measured using the one-cup method.
結果は第1図に示す通りである。毛朱子エタノール抽出
物0.1%配合クリームを塗布した部位では、非配合ク
リーム塗布部位と比較して、又、苑朱子n−ヘキサン抽
出物1%配合軟膏剤は、非配合軟膏剤と比較して、それ
ぞれ有意に皮脂分泌量が増加した。The results are shown in FIG. The area where the cream containing 0.1% Mao Shuzi ethanol extract was applied was compared to the area where the cream was not applied, and the ointment containing 1% Soon Shuzi n-hexane extract was compared to the non-containing ointment. In both cases, sebum secretion increased significantly.
第1図は毛朱子エタノール抽出物0.1%配合クリーム
および灸朱子n−ヘキサン抽出物1%配合軟膏剤をヒト
に適用したときの皮脂分泌促進効果を示した図面である
。FIG. 1 is a diagram showing the sebum secretion promoting effect when a cream containing 0.1% of Mao Zhuzi ethanol extract and an ointment containing 1% Moxibustion Zhuzi n-hexane extract were applied to humans.
Claims (1)
媒抽出液および/またはその溶媒を留去して得られる抽
出物A solvent extract of sagebrush and/or an extract obtained by distilling off the solvent, which is characterized by having a sebum secretion promoting effect.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62120367A JP2522943B2 (en) | 1987-05-18 | 1987-05-18 | Anchovy extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62120367A JP2522943B2 (en) | 1987-05-18 | 1987-05-18 | Anchovy extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63284110A true JPS63284110A (en) | 1988-11-21 |
JP2522943B2 JP2522943B2 (en) | 1996-08-07 |
Family
ID=14784446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62120367A Expired - Lifetime JP2522943B2 (en) | 1987-05-18 | 1987-05-18 | Anchovy extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2522943B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100542824B1 (en) * | 1998-08-11 | 2006-04-28 | 주식회사 엘지생활건강 | Skin composition for wrinkle improvement, elasticity improvement and wound healing, including collagen synthesis promoter |
US20130337089A1 (en) * | 2011-03-10 | 2013-12-19 | University-Industry Cooperation Group Of Kyung Hee University | Composition for preventing or treating hearing loss |
US20150050364A1 (en) * | 2012-04-18 | 2015-02-19 | University-Industry Cooperation Group Of Kyung Hee University | Composition for treating or preventing tinnitus |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5279033A (en) * | 1975-12-24 | 1977-07-02 | Sunstar Inc | Cosmetics |
JPS5692208A (en) * | 1979-12-27 | 1981-07-25 | Sunstar Inc | External preparation for skin whitening |
-
1987
- 1987-05-18 JP JP62120367A patent/JP2522943B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5279033A (en) * | 1975-12-24 | 1977-07-02 | Sunstar Inc | Cosmetics |
JPS5692208A (en) * | 1979-12-27 | 1981-07-25 | Sunstar Inc | External preparation for skin whitening |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100542824B1 (en) * | 1998-08-11 | 2006-04-28 | 주식회사 엘지생활건강 | Skin composition for wrinkle improvement, elasticity improvement and wound healing, including collagen synthesis promoter |
US20130337089A1 (en) * | 2011-03-10 | 2013-12-19 | University-Industry Cooperation Group Of Kyung Hee University | Composition for preventing or treating hearing loss |
US9694043B2 (en) | 2011-03-10 | 2017-07-04 | University-Industry Cooperation Group Of Kyung Hee University | Composition for preventing or treating hearing loss |
US20150050364A1 (en) * | 2012-04-18 | 2015-02-19 | University-Industry Cooperation Group Of Kyung Hee University | Composition for treating or preventing tinnitus |
Also Published As
Publication number | Publication date |
---|---|
JP2522943B2 (en) | 1996-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101364470B1 (en) | Pharmaceutical composition for treating acne | |
JP2540581B2 (en) | Topical | |
JPH06128143A (en) | External agent for skin | |
JPS61263905A (en) | Cosmetic | |
JP2000191493A (en) | Medicated cosmetic | |
JPH0551314A (en) | Skin cosmetics | |
JP2501593B2 (en) | Topical agent for suppressing melanin production | |
JPS63284110A (en) | Extract of seed of cuscuta japonica choisy | |
JPH0296581A (en) | Biotin ester and skin ointment and hair tonic using the ester | |
JP2820527B2 (en) | Hair cosmetics | |
JP4105498B2 (en) | A composition effective for prevention and alleviation of symptoms of atopic disease | |
JPH0665045A (en) | Skin external preparation | |
KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
JP4220687B2 (en) | Testosterone 5α-reductase inhibitor | |
JP3822517B2 (en) | Topical skin preparation | |
JPH1045559A (en) | Cosmetic | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JP2006083112A (en) | Skin care preparation for external use | |
JPS61254510A (en) | External agent for skin | |
JP2811479B2 (en) | Hair restoration | |
JP2004137166A (en) | Skin care preparation for external use, cell activator and antioxidant | |
JPS61289021A (en) | Hair cosmetic | |
JP2003137766A (en) | Collagen production promoter for external use for skin, and hyaluronic acid production promoter for external use for skin | |
JPH0248512A (en) | Hair tonic | |
JPH1017440A (en) | Hair growing and restoring agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |